CIK 0000818686
- Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 39148213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-17 | Daniell Richard Exec. VP, European Commercial | Option exercise | +1,297 | 1,297 | ||
| 2019-03-17 | Daniell Richard Exec. VP, European Commercial | Option exercise · Restricted Share Units | −1,297 | 1,297 | ||
| 2019-03-17 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise | +2,358 | 5,332.39 | ||
| 2019-03-17 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise · Restricted Share Units | −2,358 | 2,359 | ||
| 2019-03-17 | McClellan Michael James EVP, Chief Financial Officer | Option exercise | +660 | 12,990.27 | ||
| 2019-03-17 | McClellan Michael James EVP, Chief Financial Officer | Option exercise · Restricted Share Units | −660 | 661 | ||
| 2019-03-17 | Griffin Deborah A Chief Accounting Officer | Option exercise | +943 | 943 | ||
| 2019-03-17 | Griffin Deborah A Chief Accounting Officer | Option exercise · Restricted Share Units | −943 | 944 | ||
| 2019-03-17 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise | +747 | 16,840.51 | ||
| 2019-03-17 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise | +265 | 17,105.51 | ||
| 2019-03-17 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise · Restricted Share Units | −747 | 748 | ||
| 2019-03-17 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise · Restricted Share Units | −265 | 266 | ||
| 2019-03-17 | Dethlefs Sven EVP Global Marketing&Portfolio | Option exercise | +1,179 | 9,780.7 | ||
| 2019-03-17 | Dethlefs Sven EVP Global Marketing&Portfolio | Option exercise · Restricted Share Units | −1,179 | 1,179 | ||
| 2019-03-12 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise | +2,444 | 5,418.39 | ||
| 2019-03-12 | Stark David Matthew Exec. VP Chief Legal Officer | Sale | −2,444 | $15.82 | $39K | 2,974.39 |
| 2019-03-12 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise · Restricted Share Units | −2,444 | 0 | ||
| 2019-03-12 | O'Grady Brendan P. EVP, North America Commercial | Option exercise | +738 | 2,126.49 | ||
| 2019-03-12 | O'Grady Brendan P. EVP, North America Commercial | Sale | −738 | $15.67 | $12K | 1,388.49 |
| 2019-03-12 | O'Grady Brendan P. EVP, North America Commercial | Option exercise · Restricted Share Units | −738 | 0 |
Page 65 of 76 · 1,517 trades